Asian Stocks Fall as Surging Bond Yields Rattle Markets 
Pope Leo Backs Press Freedom After White House Media Ban 
Trump Administration Plans Faster FDA Reviews for Smoke-Free Nicotine Products 
Saudi Arabia, Turkey and Pakistan Plan Urgent Defence Talks Over Houthi Attacks 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
Gold Prices Fall as Treasury Yields Rise on Fed Rate Hike Bets 
Japan Private-Sector Growth Slows as Domestic Demand Weakens 
Netanyahu Defends Israel at UN as Delegates Stage Walkout 
RBI Uses $10 Billion Currency Swaps to Drain Excess Rupee Liquidity 
US Bans Canadian Alcohol, Motorcycles as Trade War Escalates 
Oil Prices Jump 3% as Houthi Attack Revives Supply Fears 
Saudi Arabia Seeks Military Support as Houthi Attacks Escalate 
Dollar Falls as Oil Eases, Yen Jumps on Intervention Signals 
Wall Street Ends Flat as Oil, Treasury Yields and Fed Jitters Rattle Markets 
Canada Unveils Bill to Fast-Track Major Resource Projects 
Add as a preferred source on Google
U.S. President Donald Trump announced sweeping new trade tariffs Thursday evening, including a 100% levy on imported pharmaceutical products, marking one of his most aggressive moves to date in reshaping America’s trade policy. The new tariffs, set to take effect October 1, will also include a 25% duty on heavy truck imports, 50% on kitchen and bathroom fittings, and 30% on upholstered furniture.
According to Trump, the pharmaceutical tariffs will apply to all branded or patented products, though companies actively building manufacturing plants in the United States will be exempt. He specified that firms must have already broken ground or begun construction on U.S. facilities to qualify. Trump framed the move as a matter of national security and a necessary step to reduce dependency on foreign drug imports.
The United States imported over $212 billion worth of pharmaceutical products in 2024, government data shows. Trump has long criticized this reliance, arguing that it threatens U.S. security and weakens domestic industries. Earlier this year, he demanded that 17 major drugmakers lower domestic drug prices while raising them abroad to balance profits. In August, Trump warned he could hike tariffs as high as 250%, signaling the seriousness of his push for reshoring production.
The tariff threats have already spurred huge investment pledges from global pharma companies. Roche committed to investing $50 billion, while Novartis announced $23 billion in U.S. facilities. American firms including Johnson & Johnson (NYSE:JNJ) and Eli Lilly and Company (NYSE:LLY) are also ramping up domestic operations to hedge against the new trade policies.
These tariffs extend beyond pharmaceuticals, targeting industries like heavy trucks, fittings, and furniture—sectors Trump says need protection to revive U.S. manufacturing and safeguard jobs. While the full impact of these measures on trade partners remains unclear, they underscore the administration’s continued reliance on tariffs as a core tool in its economic agenda.
